Oncology based Indications

DelveInsight’s specialized oncology reports proffer insights into recent treatment approaches, epidemiology, and market trends.

Notizia

Business Consultant, Notizia, Oncology based Indications, Pharma Consultant

FDA gives thumbs-up to Balversa The U.S. FDA has granted approval of Balversa (erdafitinib) to Belgium-based Janssen Pharmaceutica, for the...

Read More

Notizia

Business Consultant, DelveInsight's Drug Report, DelveInsight's Indication Pipeline Reports, DelveInsight's Oncology based Reports, Notizia, Oncology based Indications, Pharma Consultant

Selumetinib gets the U.S. Breakthrough Therapy Designation Selumetinib- an investigational drug, for the treatment of pediatric patients...

Read More

A helping hand in treatment of CRC

Business Consultant, DelveInsight's Drug Report, DelveInsight's Indication Pipeline Reports, Oncology based Indications, Pharma Consultant, Snippets

Patients suffering from Colorectal Cancer (CRC) usually gets affected with distant organ metastases spreading the tumor to other parts of...

Read More

Neuroendocrine tumors (NETs): The complex group of tumors

Articles, Business Consultant, DelveInsight's Oncology based Reports, Oncology based Indications, Pharma Consultant

Neuroendocrine tumors (NETs) consists of complex group of tumors that develop predominantly in the digestive or respiratory tracts, but can...

Read More

Japan Manages to Stand Apart from Global Hepato Cellular Carcinoma Crowd

Articles, Business Consultant, Oncology based Indications, Pharma Consultant

Hepato Cellular Carcinoma (HCC) Not all deadly battles are lost. Some are won too.It is without the slightest doubt that the ones won are...

Read More

The Business Cocktail

Business Consultant, Oncology based Indications, PD-1 and PD-L1 inhibitors, Pharma Consultant, The Business Cocktail

AstraZeneca dragout Entasis files to fund antibiotic phase 3 for USD 86 Million IPO Massachusetts-based Entasis Therapeutics has spun out...

Read More
Close